Interpreting Hormone Levels: What Your Lab Results Mean in 2026

Interpreting hormone levels requires understanding both numerical values and clinical context, as normal ranges vary significantly based on age, sex, and testing methodology. For testosterone, healthy adult men typically show 300-1,000 ng/dL total testosterone and 50-210 pg/mL free testosterone, while women maintain 8-60 ng/dL total testosterone. Estradiol levels in premenopausal women fluctuate between 30-400 pg/mL depending on menstrual cycle phase, dropping to under 30 pg/mL after menopause. Thyroid-stimulating hormone (TSH) should fall between 0.4-4.0 mIU/L, though many clinicians prefer the tighter range of 1.0-2.5 mIU/L for optimal function. Lab results must be interpreted alongside symptoms, medical history, and individual factors rather than relying solely on reference ranges, which represent the middle 95% of the population tested.

Understanding Reference Ranges and Their Limitations

Reference ranges on lab reports represent the values found in 95% of the tested population, but this statistical approach has significant limitations for individual patient care. The remaining 5% of healthy individuals naturally fall outside these ranges, while some people within "normal" ranges may still experience symptoms of hormonal imbalance. Age-specific references provide more accurate context. For example, testosterone levels naturally decline by 1-2% annually after age 30, so a 60-year-old man with testosterone at 350 ng/dL may be normal for his age group but could benefit from evaluation if experiencing symptoms. Similarly, estradiol levels in postmenopausal women under 30 pg/mL are statistically normal but may not be optimal for bone health and cardiovascular protection. Laboratory methodology also affects reference ranges. Different assays can produce varying results for the same sample, particularly for hormones measured in small quantities like free testosterone or free T3. The electrochemiluminescence immunoassay (ECLIA) method typically used for testosterone provides different ranges than older radioimmunoassay techniques.

Testosterone Levels: Total vs Free Measurements

Total testosterone measures all testosterone in the blood, including the 98% bound to proteins and the 2% that circulates freely. Free testosterone represents the bioactive portion that actually affects your cells and tissues. Men with normal total testosterone but low free testosterone may still experience symptoms of low T due to increased sex hormone-binding globulin (SHBG) or albumin levels. Free testosterone ranges differ significantly between men and women. Healthy adult men typically maintain 50-210 pg/mL free testosterone, while women show 0.3-3.0 pg/mL. Age affects these levels dramatically: men in their 20s average around 120 pg/mL free testosterone, while men over 70 may show levels around 60 pg/mL. The testosterone-to-estradiol ratio provides additional insight, particularly for men. A healthy ratio typically falls between 10:1 and 40:1. Men with ratios below 10:1 may experience symptoms related to estrogen dominance, including mood changes, reduced libido, and difficulty building muscle mass. Our HRT complete guide explains how testosterone replacement therapy can help restore optimal ratios.

Estradiol and Estrogen Metabolites

Estradiol levels in women change dramatically throughout the menstrual cycle, making timing important for accurate interpretation. During the follicular phase (days 1-13), levels typically range from 30-120 pg/mL, peak at 150-400 pg/mL around ovulation, and stabilize at 80-150 pg/mL during the luteal phase. Postmenopausal women generally show levels below 30 pg/mL. For women on hormone replacement therapy, target estradiol levels depend on the indication and delivery method. Menopausal symptom relief typically requires 40-100 pg/mL, while bone protection may need higher levels around 50-150 pg/mL. The estradiol guide provides detailed information about optimal dosing strategies. Estrogen metabolite testing offers additional insights into hormone processing. The 2-hydroxyestrone to 16-hydroxyestrone ratio should ideally exceed 2:1, indicating healthy estrogen metabolism. Lower ratios suggest increased production of potentially harmful metabolites and may warrant dietary modifications or supplementation with nutrients like indole-3-carbinol. Men also require estradiol monitoring, particularly during testosterone therapy. Male estradiol levels typically range from 10-40 pg/mL, with levels above 50 pg/mL potentially causing side effects including mood changes, water retention, and gynecomastia.

Thyroid Hormone Interpretation

Thyroid function testing involves multiple markers that must be interpreted together for accurate assessment. Thyroid-stimulating hormone (TSH) is the primary screening test, with normal ranges between 0.4-4.0 mIU/L. However, many functional medicine practitioners prefer TSH levels between 1.0-2.5 mIU/L for optimal metabolic function. Free T4 levels should range from 0.8-1.8 ng/dL, while free T3 typically falls between 2.3-4.2 pg/mL. The T4-to-T3 conversion ratio provides insight into peripheral thyroid hormone metabolism. Poor converters may show normal T4 but low T3 levels, indicating potential selenium deficiency or chronic stress affecting deiodinase enzyme function. Reverse T3 (rT3) measurements help identify metabolic stress or chronic illness. Normal rT3 levels range from 8-25 ng/dL, but elevated levels above 30 ng/dL suggest impaired T4-to-T3 conversion. The free T3-to-reverse T3 ratio should exceed 2:1 for optimal thyroid function. Thyroid antibody testing identifies autoimmune thyroid conditions. Thyroid peroxidase (TPO) antibodies above 35 IU/mL or thyroglobulin antibodies above 40 IU/mL indicate Hashimoto's thyroiditis, requiring different management strategies than simple hypothyroidism.

DHEA-S and Cortisol Patterns

Dehydroepiandrosterone sulfate (DHEA-S) is a marker of adrenal function and aging. Levels peak in the mid-20s and decline steadily thereafter, dropping by approximately 2% annually. Normal ranges vary significantly by age: 20-year-olds typically show 200-500 μg/dL, while 60-year-olds may have levels around 50-200 μg/dL. Low DHEA-S levels below the 25th percentile for age may indicate adrenal fatigue, chronic stress, or premature aging. High levels above the 75th percentile could suggest adrenal hyperplasia or PCOS in women. The DHEA-S to cortisol ratio provides additional context, with optimal ratios typically ranging from 5:1 to 6:1. Cortisol testing requires careful attention to timing and collection method. Morning cortisol levels should range from 10-25 μg/dL, reflecting the natural circadian peak. Four-point salivary cortisol testing provides a more accurate assessment of daily cortisol patterns, showing the expected decline from morning highs to evening lows below 1.0 μg/dL. Abnormal cortisol patterns include flat curves (indicating adrenal fatigue), elevated evening cortisol (suggesting chronic stress), or inverted patterns (showing severe adrenal dysfunction). These patterns often correlate with sleep disturbances, mood changes, and metabolic dysfunction regardless of absolute values.

Insulin and Metabolic Markers

Insulin resistance assessment requires multiple markers beyond basic glucose testing. Fasting insulin levels should remain below 10 μIU/mL, with levels above 15 μIU/mL indicating significant insulin resistance. The homeostatic model assessment (HOMA-IR) calculates insulin resistance using the formula: (fasting glucose × fasting insulin) ÷ 405. Values above 2.5 suggest insulin resistance. Hemoglobin A1c reflects average blood sugar over 2-3 months, with optimal levels below 5.4% for metabolic health. Levels between 5.5-5.9% indicate prediabetes, while values of 6.0% or higher suggest diabetes. However, A1c can be misleading in individuals with altered red blood cell turnover or certain genetic variants. Advanced markers like fructosamine and glycated albumin provide shorter-term glycemic control assessment over 2-3 weeks. These tests prove particularly useful for monitoring treatment adjustments or in situations where A1c may be unreliable. The triglyceride-to-HDL ratio offers insight into insulin sensitivity and cardiovascular risk. Ratios below 2:1 indicate good metabolic health, while ratios above 4:1 suggest significant insulin resistance and increased cardiovascular risk.

Timing and Collection Considerations

Hormone levels fluctuate significantly throughout the day, making collection timing critical for accurate interpretation. Testosterone peaks in early morning for most men, typically between 6-8 AM, then declines by 20-30% throughout the day. Testing should occur between 7-10 AM for most accurate assessment. For premenopausal women, cycle day affects multiple hormones. Estradiol and LH testing should occur on specific cycle days depending on the clinical question: day 3 for baseline assessment, day 14 for ovulation confirmation, or day 21 for luteal phase evaluation. Progesterone testing typically occurs 7 days after ovulation (around day 21 of a 28-day cycle). Stress, exercise, and sleep significantly impact hormone levels. Intense exercise can suppress testosterone for 24-48 hours, while sleep deprivation affects cortisol patterns and growth hormone release. Patients should avoid major stressors, maintain normal sleep patterns, and fast for 8-12 hours before most hormone testing. Medications can also influence results. Bioidentical hormones may interfere with certain assays, while birth control pills suppress natural hormone production. The hormone testing guide provides specific preparation instructions for different tests.

When to Retest and Monitor Progress

Abnormal hormone results often require confirmation through repeat testing before initiating treatment. Single abnormal values can result from laboratory error, timing issues, or temporary physiological changes. Most clinicians recommend retesting within 2-4 weeks for significantly abnormal results. Treatment monitoring depends on the specific hormone and intervention used. Testosterone replacement therapy requires monitoring every 3-6 months initially, checking both total and free testosterone along with estradiol and hematocrit. Women using HRT delivery methods typically need monitoring every 6-12 months once stable. Thyroid hormone adjustments require 6-8 weeks for full equilibration before retesting. More frequent testing can lead to unnecessary dose changes and clinical instability. Annual monitoring suffices for stable patients on consistent dosing. Baseline testing establishes individual patterns and optimal ranges for future comparison. Many people feel best at different points within reference ranges, making personal baseline values more clinically relevant than population averages.

Frequently Asked Questions

Sources

1. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578-87. PMID: 21683825
2. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone. J Clin Endocrinol Metab. 2007;92(2):405-13. PMID: 17090633
3. Santoro N, Randolph JF Jr. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am. 2011;38(3):455-66. PMID: 21961714
4. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-751. PMID: 25266247
5. Dhindsa S, Miller MG, McWhirter CL, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186-92. PMID: 20200299
6. Lobo RA, Davis SR, De Villiers TJ, et al. Prevention of diseases after menopause. Climacteric. 2014;17(5):540-56. PMID: 24969415
7. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90(9):5483-8. PMID: 16148345
8. Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol. 2013;78(3):321-9. PMID: 23121642